Florida Society of Clinical Oncology: Florida Society of Clinical Oncology: The Voice of Oncology in FloridaThe Voice of Oncology in Florida

FLASCOFLASCO

2018 2018 –– 2019 2019 LeadershipLeadership

Richard McDonough MD President

Luis Raez MD Vice President

Barry Berman MD Secretary

Maen Hussein, MD Treasurer

Michael Diaz MD Immediate Past President Syed Abid MD Sikander Ailawadhi MD Ahmed Al-Hazzouri MD David Asher MD Christopher Bryant MD Robert Cassell MD Sarah Cevallos Melody Chang RPh Chakra Chaulagain MD, FACP Gerardo Colon-Otero MD Jennifer Cultrera MD Jose Davila MD Craig Deligdish MD Dina Dumercy McHenry PharmD Gail Erentreich Ana Espinosa DNP, MBA, RN, OCN Benjamin Farnia MD Steven Fein MD Karen Fields MD Jessica Frakes MD Laura Freedman MD Manoj Gadara MD Jorge Garcia PharmD, MS, MBA Faithlore Gardner MD Thomas George MD, FACP Shelly Glenn Terry Gruchow PA-C Ardeshir Hakam MD, MBA William Harrer MD Eric Harris DO Nalini Hasija MD Randal Henderson MD John Hiemenz MD, FACP, FIDSA Mohammad (MJ) Jahanzeb MD Kun Jiang MD, PhD Sachin Kamath MD Farah Khalil MD, FCAP Waseem Khan MD Jeanelle King PA-C KS Kumar MD, FACP Richard Levine MD Mayra Lima MSN, ARNP, FNP-C Loretta Loftus MD, MBA Shannon Luker RN, OCN, CBCN Reshma Mahtani DO Yan Makeyev MD Adrianne Mallen MD Merry-Jennifer Markham MD Alan Marks MD Shahla Masood MD Richard McDonough MD Tarek Mekhail MD Joseph Mignone MD Mehdi Moezi MD Daniel Morris MD Anay Moscu PharmD Zeina Nahleh MD, FACP Smitha Pabbathi MD Paresh Patel MD Herman Powery II PharmD Brendan Prendergast MD Ian Qureshi DO, PhD Luis Raez MD Brian Ramnaraign MD Brittany Rogers MD Joseph Rosenblatt MD Jose Sandoval-Sus MD Edgardo Santos MD, FACP Shalin Shah DO Aulakh Sonikpreet MD, MBBS Jason Starr DO Amanda Stephens DO Winston Tan MD Scott Tetreault MD Beau Toskich MD Teri Valls Maggie Wiegandt MBA Jonathan Zager MD, FACS

Dorothy Phillips

FLASCO Executive Director

Multi-

Disciplinary Pharmacy

Nursing/

Patient

Navigator Administrator

C ourse Description: The Florida Society of Clinical Oncology is hosting a two day meeting designed for medical oncologists,

hematologists, radiation oncologists, surgical oncology, pathologists, oncology nurses, nurse practitioners, pharmacists, physician assistants, oncology administrators, residents, and fellows that manage heath care for cancer patients. This conference will provide an emphasis on multidisciplinary collaboration among all professional

health care teams with dynamic educational tracks that focus on specific driven topics addressing the current and future changes in the landscape of cancer care.

The 2018 Fall meeting will center on the multi-disciplinary presentations and case studies in Neoadjuvant Breast Cancer, CLL, and Hereditary Genetics focusing on Prostate Cancer which include the collaboration of top clinicians, as well as up-to-date information on Healthcare Disparities. Additional sessions include information on hot topics in nursing, patient navigation, pharmacy, and administration.

FLASCO Fall Session Features:

Four Educational Tracks

REGISTER ONLINE: www.flasco.org/events/2018-flasco-fall-session/

FLASCO 2018 FALL SESSION November 8-10, 2018

Orlando World Center Marriott

8701 World Center Dr│ Orlando, Florida 32821

K ey Note Speaker:

Monica Bertagnolli, MD, FACS

President, American Society of Clinical Oncology

Caring for Every Patient, Learning from Every Patient

www.FLASCO.org

Friday, November 9, 2018

4:00 – 6:00 PM Poster Presentations ~ View the latest research efforts

6:00 – 7:30 PM Reception/Visit Exhibits/Cash Bar Available

7:30 – 10:00 PM

Dinner & Program ~ Rick McDonough, MD, FLASCO President ~ Welcome Caring for Every Patient, Learning from Every Patient

Moderator: Luis Raez, MD Key Note Speaker: Monica Bertagnolli, MD, FACP, ASCO President

Saturday, November 10, 2018

6:30 — 8:00 AM Registration/Breakfast/Visit Exhibitors

8:00 – 8:30 AM Opening Remarks & Supporter Recognition

Edgardo Santos, MD, FACP, FLASCO Program Chairman, Boca Raton Regional Hospital

8:30 – 9:30 AM Precision Medicine ~ Moderator: Eric Harris, DO, Florida Cancer Specialists

Speaker: Howard McLeod, PharmD, Moffitt Cancer Center

9:30 – 10:15 AM Break/Visit Exhibitors

Multi-Disciplinary Pharmacy Nursing/Navigator Administrator

10:15 – 11:45 AM

Neoadjuvant Breast Caner

MODERATOR

Zeina Nahleh, MD, FACP Cleveland Clinic Florida

MEDICAL ONCOLOGY

Mohammad Jahanzeb, MD, FACP University of Miami

RADIATION

Amber Orman, MD Florida Hospital

SURGICAL

Stephanie Valente, DO Cleveland Clinic Ohio

PATHOLOGY

Laila Khazai, MD Moffitt Cancer Center

CASE STUDY

Sofia Palacio, MD University of Miami

10:15 – 11:00 AM

Welcome Jorge Joanh García, PharmD, MS, MHA, MBA Baptist Hospital of Miami

Oral Oncolytics MODERATOR

Ray Bailey, RpH FCS Rx-To-Go

SPEAKERS

Mabel Arslanyan, PharmD, BCOP Baptist Hospital of Miami Jessica Unzaga, PharmD, BCPS, BCOP Baptist Hospital of Miami

********** 11:00 AM – 12:00 PM

Medical Marijuana SPEAKER

Victoria Robinson, PharmD Memorial Regional Hospital Marcos Rejtman, DO, HMDC Memorial Cancer Institute

10:15 — 11:00 AM

Beat the Cancer, Save Your Heart

MODERATOR

Shannon Luker, RN, OCN, CBCN Parrish Medical Center

SPEAKERS

Natalee Roper, RN,BSN,CHPN Moffitt Cancer Center Cathy Elstner RN, BSN Moffitt Cancer Center

************** 11:00 - 11:45 AM

Navigating Patients: Understanding Clinical Trials

MODERATOR

Katie Goodman, RN, BSN Florida Cancer Specialists

SPEAKERS

Christin Hart, RN, BSN, OCN Florida Hospital Cancer Institute Jose Ortiz-Pagan, Survivor Beth Davison, MSN, RN Leukemia & Lymphoma Society

10:15 -11:45 AM

Difficult Conversations SPEAKER

Beth Sussman Executive Coach

************** Discussion Panel

COMMUNITY BASED

Gail Erentreich Cancer Care Centers of Brevard

HOSPITAL BASED

Speaker TBD TBD

ACADEMIC CENTER

Josh Mattson Mayo Clinic Florida

Lunch ~ Choice of Networking (NON-CE), Rare Disease Presentation (NON-CE), or Breast Cancer Presentation (Continuing Education included)

11:45 AM – 12:45 PM

Multi-Disciplinary Pharmacy Nursing/Navigator Administrators

12:45 — 2:15 PM

CLL MODERATOR

Asher Chanan0Khan, MD Mayo Clinic Florida

HEMATOLOGIST

Jan A. Burger, MD, PhD MD Anderson Cancer Center (invited)

CASE STUDY

Aulakh Sonikpreet, MD Mayo Clinic Florida Jeremy Ramdial, MD University of Miami

2:20 — 3:30 PM

Hereditary Genetics focusing on Prostate Cancer

MODERATOR

Edgardo Santos, MD Lynn Cancer Institute

MEDICAL ONCOLOGIST

Louise Morrell, MD Lynn Cancer Institute Jingsong Zhang, MD, PhD Moffitt Cancer Center

PATHOLOGY

Jasreman Dhillon, MD Moffitt Cancer Center

RADATION ONCOLOGIST

Tim Williams, MD Boca Raton Regional Hospital

CASE STUDY

Brittany Rogers, MD University of Florida

1:00 – 1:55 PM MODERATOR

Dina Dumercy McHenry, PharmD, BCOP, BCPS Baptist Hospital of Miami

Revenue Integrity SPEAKERS

Julia Khalil, PharmD, BCPS UMHC/Sylvester Comprehensive Cancer Center Jorge Joanh García, PharmD, MS, MHA, MBA Baptist Hospital of Miami

**********

2:00 – 2:45 PM Patient Assistance Best Practices Sarah Francis, PharmD, BCOP Jackson Memorial Hospital

**********

2:45 – 3:30 PM Changes in Oncology Clinical Trials

Landscape Anay Moscu, PharmD, BCPS, BCOP Moffitt Cancer Center

12:45 - 2:25 PM

Supportive Care Throughout the Cancer Journey

MODERATORS

Ana Rosa Espinosa, DNP, MBA, RN, OCN Memorial Cancer Institute Adrienne Vazquez, Guerra, MSN, ACNP-BC, AOCNP University of Miami

PALLIATIVE CARE

Mayra Lima, MSN, ARNP, FNP-C University of Miami

PAIN MANAGEMENT

Ana Garcia, ARNP Memorial Cancer Institute

SURVIVORSHIP

Jessica McMillan, DNP, FNP, ARNP-BC Mayo Clinic Florida

********** 2:30 - 3:30 PM

Shaping the Future of Healthcare through Nursing

MODERATOR

Cheryl Habaue, MSN, RN, CCRP Memorial Cancer Institute

SPEAKER

Andrea Uitti, DNP, RN Florida Action Coalition

12:45 - 2:25 PM

Prior Authorizations MODERATOR

Sarah Cevallos Florida Cancer Specialists

PANELISTS

David Segal (invited) Aetna FL Blue Rep (invited) Blue Cross Blue Shield Jennifer Malin, MD (invited) United Healthcare Andrew Hertler, MD New Century Health Brian Hunis, MD Memorial Cancer Institute Shalin Shah, DO (invited) Florida Cancer Specialists Amanda Brahim, PharmD Memorial Healthcare System Shelli Johnson Cancer Care Centers of Brevard Candice Banks Cancer Survivor

********** 2:25 - 3:00 PM

Patient Collections SPEAKER

TBD

3:30 PM Adjourn

Upon completion of the conference you will be able to:

1. Discuss new treatment options of Neoadjuvant Breast Cancer, CLL, and Prostate Cancer

giving the different perspectives of multi-disciplinary physicians.

2. Learn the new innovations in hereditary genetics.

3. Explain the importance of oral oncologics, medical marijuana, and revenue integrity for

oncology pharmacists.

4. Learn the effects of oncology care on cardiovascular health. Explain the importance of

clinical trial options in a patient’s care plan.

5. Learn strategies to better perform when having difficult conversations with coworkers

and patients.

CONFERENCE OBJECTIVES

Page 3 of 4Page 3 of 4 FLASCO CONFERENCE GOAL FLASCO CONFERENCE GOAL is to continue to develop a comprehensive

range of programs that emphasize the latest developments, state-of-the-art information

and enhanced educational strategies for the intra-professional team.

CONFERENCE OUTCOME MEASURES:CONFERENCE OUTCOME MEASURES:

Participants should be able to apply the knowledge acquired during this Participants should be able to apply the knowledge acquired during this

conference to improve their competence, performance, and/or patient outcomes conference to improve their competence, performance, and/or patient outcomes

in the daily treatment of their patients. To measure attendees perceptions of in the daily treatment of their patients. To measure attendees perceptions of

these gains, they will complete an evaluation form at the end of the conference.these gains, they will complete an evaluation form at the end of the conference.

ACCREDITATION STATEMENTS Physicians: The Medical Educator Consortium is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

FLASCO has applied to the Medical Educator Consortium to approve this live activity for a maximum of 6.5 AMA PRA Category 1 Credits™.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The Medical Educator Consortium and Florida Society of Clinical Oncology. The Medical Educator Consortium is accredited by the ACCME to provide continuing medical education for physicians.

Disclosure Statement:

The Medical Educator Consortium (MEC) adheres to the ACCME Standards for Commercial Support. All persons that will be in a position to control the content of the CME Activity are required to disclose all relevant financial relationships. Faculty disclosure forms outlining this information will be made available to all participants prior to educational activity. MEC has also implemented a mechanism to identify and resolve all conflicts of interest prior to the education activity being delivered to learners. The source of all support from commercial interests will also be disclosed to learners prior to the beginning of the educational activity.

Nurses and Patient Navigators: Approval for nurses to receive CE has been applied for to the Southern Florida Chapter of The Leukemia & Lymphoma Society under provider number 50-12996, to award up to 6.5 continuing education contact hours through the Florida Board of Nursing. FLASCO maintains responsibility for this program.

Pharmacists: This program is not yet approved for CME credit. CME credit has been applied for from Memorial Hospital. Total number of approved credits is yet to be determined. FLASCO maintains responsibility for this program.

This conference is proudly co-sponsored by the

following companies:

2018 Corporate Members As of 6/27/2018

Diamond Elite Alexion Amgen AstraZeneca Bristol-Myers Squibb Celgene Genentech Merck Pfizer Oncology Takeda Oncology Teva Pharmaceuticals

Diamond Astellas Bayer Oncology Boehringer Ingelheim EMD Serono Lilly Oncology Pfizer Biosimilars Sandoz Sanofi Genzyme Seattle Genetics

Platinum AbbVie Adaptive Biotechnologies enterade® Eisai Exelixis Foundation Medicine Guardant Health Heron Therapeutics Incyte INSYS Therapeutics J & J HealthCare Systems Kite Pharma NanoString Technologies Oncology Supply/ION Solutions Pharmacyclics Puma Biotechnology Sun Pharma Taiho Oncology, Inc. Walgreens

Gold Gilead Sciences IPSEN Biopharmaceuticals Novartis Oncology

Silver Agios Array Biopharma Biodesix Clovis Oncology Helsinn Kroger Specialty Pharmacy Lexicon Pharmaceuticals Novocure Spectrum Sysmex TerSera Therapeutics TESARO

FLASCO acknowledges the following companies as 2018 FLASCO Corporate Members

Page 4 of 4Page 4 of 4

Before or on Sept. 15, 2018 After Sept. 15, 2018

FLASCO Regular Members Complimentary $50.00

FLASCO Affiliate Members Complimentary $50.00

FLASCO Associate Members Complimentary $50.00

FLASCO Courtesy Members $200.00 $250.00

Non-FLASCO Members $250.00 $300.00

Registration is complimentary prior to September 15, 2018 for FLASCO Regular, Affiliate and Associate Members.

Reminder: To keep your complimentary membership active and in good standing, FLASCO members are encouraged to participate in at least one FLASCO or FLASCO co-sponsored event prior to December 31, 2020, or make a minimum contribution of $50 to FLASCO Foundation, Inc.

FLORIDA SOCIETY OF CLINICAL ONCOLOGY 10022 Water Works Lane │ Riverview, FL │ 33578 Phone: 813.677.0246 ext. 102 │ Fax: 813.677.0559

Email: Dorothy.Green@FLASCO.org

FLASCO reserves the right to alter this program without prior notice. Speakers and agenda are subject to change.

A block of rooms has been reserved at the

Orlando World Center Marriott

8701 World Center Dr │ Orlando, Florida 32821

Reservations can be made by calling 1-888-789-3090 Or by visiting

https://book.passkey.com/go/FLASCO2018FallSession

Please contact the hotel directly if room arrangements are needed and mention your attendance to the

FLASCO Fall Session to receive the discounted rate of $179 plus applicable fees and taxes.

DEADLINES - The Orlando World Center Marriott has requested that all

reservations be made prior to September 15, 2018. After that date, reservations

will only be accepted on a space available and rate available basis.

HOTEL RESERVATIONS

The Florida Society of Clinical Oncology is a statewide non-profit

organization committed to facilitating and promoting multidisciplinary

efforts to improve patient care in Florida by:

Fostering access to quality cancer care to the citizens of Florida.

Assisting the cancer practitioners in providing the most cost effective quality care for

their patients.

Acting as an advocate for Florida cancer patients and their families.

Coordinating the dissemination of information and providing an opportunity for

oncologists, physicians, and other health care professionals to network and exchange

information on cancer care.

REGISTRATION & FEESREGISTRATION & FEES

FLASCO MISSION STATEMENT